Hims & Hers Shares Rallied 22% Over Two Days. Why That Move Is Now At Risk.

Hims & Hers Shares Rallied 22% Over Two Days. Why That Move Is Now At Risk. · Investor's Business Daily
ALLISON GATLIN
3 min read

In This Article:

Hims stock rallied almost 22% over two days on enthusiasm after the FDA said it will allow compounded versions of Lilly's obesity drug.

Recommended Stories